Access to innovation is central to our work.
We study global health responses to understand why people may not have easy access to critical medicines, tests and other health technologies and design interventions that tackle those challenges.
Take a look at some of the promising health innovations we support.
For the prevention of cervical cancer in low- and middle-income countries.
Dolutegravir is a game-changing medicine for managing HIV infection, used in leading combination treatment regimens.
Child-adapted formulations ensure even very young children can access effective HIV treatment.
From once-daily pills to long-acting injections, these tools help prevent HIV transmission.
So more people can know their HIV status, and gain access to treatment or prevention.
A novel class of diagnostic technology that can quickly identify resistance to multiple tuberculosis (TB) drugs and determine which drugs are likely to work best.
Fruit-flavored, properly dosed medicines for preventing and treating all forms of tuberculosis (TB) in children.
Medicines that clear TB infection from a person’s system before it develops into active disease.
Expanded, shortened treatment options are now recommended for all populations with multidrug-resistant tuberculosis (MDR-TB).
A heat-stable alternative to oxytocin, the most used medicine for preventing life-threatening bleeding in childbirth.
To accurately identify women at high-risk of cervical cancer and connect them with preventive treatment.
Game-changing medicine delivery methods that last longer and replace the need for daily medicines, helping people successfully complete their treatments.
Reduces the risk of transmitting blood-borne infections like hepatitis C, as well as hepatitis B and HIV, when needles are shared.
An oral pill that reduces the risk of postpartum hemorrhage and can be self-administered to provide a level of protection to women giving birth unassisted
Enhanced intervention against malaria to combat mosquitoes resistant to the insecticides used on conventional nets.
Fast, reliable self-test results ensure more people access treatment.
To protect young children at greatest risk of malaria in areas with seasonal spikes in transmission.
To decentralize services and encourage more women to get tested.
A long-acting formulation of an opioid agonist treatment, which is used to reduce opioid cravings and could help reduce behaviors that contribute to the transmission of hepatitis C and other blood-borne diseases.
The world’s first vaccine that can prevent malaria in young children.
An effective medicine that averts death in women who experience extreme blood loss after giving birth.
An innovative solution to improve access to high-quality, affordable generic medicines through voluntary sharing of intellectual property rights.
Bubble continuous positive airway pressure (bCPAP) devices and oxygen blender systems offer a non-invasive way of ventilating newborns who are struggling to breathe.
A device used to measure the oxygen saturation in the blood and identify hypoxemia (low levels of oxygen in the blood).
Monoclonal antibodies are manufactured versions of proteins that mimic those the immune system generates to defend ourselves from diseases.
Medical oxygen is a lifesaving medicine with no substitute. It is used to treat a broad spectrum of illnesses and conditions, including pneumonia, COVID-19, advanced HIV, severe tuberculosis, and malaria, and is vital for maternal and child health services, surgery and critical care.
A novel vector control intervention to protect people from mosquito bites and the diseases they carry.
